Literature DB >> 8640996

Absence of focal compensatory enlargement or constriction in diseased human coronary saphenous vein bypass grafts. An intravascular ultrasound study.

T Nishioka1, H Luo, H Berglund, N L Eigler, C J Kim, S W Tabak, R J Siegel.   

Abstract

BACKGROUND: No in vivo data are available on the occurrence of compensatory enlargement or vessel constriction in diseased human coronary saphenous vein bypass grafts (SVBGs). The aim of this intravascular ultrasound (IVUS) study was to examine to what extent lumen reduction is accompanied by (1) vessel wall thickening and (2) arterial wall constriction in SVBGs. METHODS AND
RESULTS: We used IVUS to examine 43 SVBGs from 42 patients (32 men, 10 women; mean age, 72 +/- 5 years) 8 to 23 (11 +/- 4) years after SVBG. IVUS images were obtained with a 3.5F monorail ultrasound catheter with a 30-MHz frequency and were analyzed at the lesion site, the reference site, and an intermediate site. The lumen area was significantly (P < .01) decreased; the vessel wall area (SVBG cross-sectional area minus lumen area) and the plaque area (area within the external elastic lamina minus lumen area) were significantly (P < .01) increased from the reference site through the lesion site. However, SVBG cross-sectional area was the same at these three sites (24.0 +/- 8.1 versus 24.4 +/- 8.6 versus 24.5 +/- 8.6 mm2, P = NS), and the external elastic lamina area was also quite constant in each vessel (17.8 +/- 6.0 versus 17.7 +/- 6.4 versus 17.6 +/- 6.2 mm2, P = NS).
CONCLUSIONS: These in vivo IVUS data from human coronary SVBGs demonstrate that (1) no focal compensatory enlargement or vessel constriction occurred in stenotic segments compared with the reference segments and that (2) the absence of focal compensatory enlargement appears to be a potentially important factor in the progression of stenoses in coronary SVBGs.

Entities:  

Mesh:

Year:  1996        PMID: 8640996     DOI: 10.1161/01.cir.93.4.683

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  Multi-contrast high spatial resolution black blood inner volume three-dimensional fast spin echo MR imaging in peripheral vein bypass grafts.

Authors:  Frank J Rybicki; Dimitrios Mitsouras; Christopher D Owens; Amanda Whitmore; Marie Gerhard-Herman; Nichole Wake; Tianxi Cai; Qian Zhou; Michael S Conte; Mark A Creager; Robert V Mulkern
Journal:  Int J Cardiovasc Imaging       Date:  2010-03-24       Impact factor: 2.357

2.  Does remodeling occur in the diseased human saphenous vein bypass grafts? An intravascular ultrasound study.

Authors:  J Ge; F Liu; R Bhate; M Haude; G Görge; D Baumgart; S Sack; R Erbel
Journal:  Int J Card Imaging       Date:  1999-08

Review 3.  Vein graft adaptation and fistula maturation in the arterial environment.

Authors:  Daniel Y Lu; Elizabeth Y Chen; Daniel J Wong; Kota Yamamoto; Clinton D Protack; Willis T Williams; Roland Assi; Michael R Hall; Nirvana Sadaghianloo; Alan Dardik
Journal:  J Surg Res       Date:  2014-01-30       Impact factor: 2.192

Review 4.  Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications.

Authors:  Christopher D Owens
Journal:  J Vasc Surg       Date:  2009-10-17       Impact factor: 4.268

5.  Early remodeling of lower extremity vein grafts: inflammation influences biomechanical adaptation.

Authors:  Christopher D Owens; Frank J Rybicki; Nicole Wake; Andres Schanzer; Dimitrios Mitsouras; Marie D Gerhard-Herman; Michael S Conte
Journal:  J Vasc Surg       Date:  2008-04-28       Impact factor: 4.268

6.  Early Stage of Atherosclerosis in Aortocoronary Saphenous Vein Grafts: Intravascular Ultrasound Study.

Authors:  Przemysław Węglarz; Tomasz Bochenek; Grzegorz Bajor; Katarzyna Mizia-Stec; Michał Krejca; Maria Trusz-Gluza
Journal:  Braz J Cardiovasc Surg       Date:  2019-12-01

Review 7.  Insights into the pathogenesis of vein graft disease: lessons from intravascular ultrasound.

Authors:  Gavin J Murphy; Gianni D Angelini
Journal:  Cardiovasc Ultrasound       Date:  2004-07-21       Impact factor: 2.062

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.